Skip to main content

Table 2 Baseline laboratory data

From: Effectiveness and safety of SOF/VEL containing rescue therapy in treating chronic HCV-GT4 patients previously failed NS5A inhibitors-based DAAs

Variables

All patients

n = 150

SOF/VEL + RBV

n = 75

SOF/VEL/VOX

n = 75

P value

Hemoglobin (g/L)

13.36 ± 1.68

12.98 ± 1.77

13.75 ± 1.51

0.01

W.B.C (103/mm3)

5.86 ± 2.25

5.36 ± 2.09

6.36 ± 2.31

< 0.001

Platelets (103/mm3)

175 ± 76

119 ± 41

232 ± 58

< 0.001

ALT (U/L)

57 ± 36

63 ± 36

50 ± 36

0.03

AST (U/L)

60 ± 34

77 ± 36

43 ± 22

< 0.001

Albumin (g/dL)

3.76 ± 0.69

3.25 ± 0.53

4.27 ± 0.40

< 0.001

Bilirubin (umol/L)

1.07 ± 0.67

1.43 ± 0.75

0.71 ± 0.30

< 0.001

INR

1.42 ± 0.41

1.73 ± 0.36

1.1 ± 0.09

< 0.001

Creatinine (umol/L)

0.80 ± 0.25

0.71 ± 0.27

0.89 ± 0.20

< 0.001

Random glucose (mmol/L)

127 ± 61

122 ± 51

132 ± 70

0.31

HCV PCR (log10)

5.20 ± 1.38

5.24 ± 1.21

5.17 ± 1.54

0.74

FIB-4

3.12 ± 2.30

4.79 ± 2.12

1.45 ± 0.78

< 0.001

Cirrhosis (yes)

75 (50%)

75 (100)

0

NA

Mean CTP score if cirrhotic

7.27 ± 0.48

7.27 ± 0.48

0

NA